CK Science is recruiting for a rare opportunity for a Head of Research to join a biopharmaceutical company created to translate CRISPR-Cas9, a breakthrough gene-editing technology, into transformative medicines for serious human genetic diseases.
The organisation is looking for a Head of Research to join their multi-disciplinary team of scientific experts, including senior industry executives, world-renowned academics, and clinicians. The main purpose of this role is to build a research team with roughly 15 to 20 researchers over the next to 18 to 24 months.
The research team will be expected to support non-clinical research and development activities, but also to conduct basic research in support of building the technology platform around CRISPR-Cas9.
This is an exciting opportunity to join a modern organisation utilising breakthrough gene-editing technology, this role will be based at their site in Hertfordshire on a full time permanent basis.